Disclosures for "The Safety and Efficacy of Monoamine Oxidase-B Inhibitors as Add-on Therapy to Dopamine Agonists for the Treatment of Parkinson’s Disease: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials"
-
Mr. Shahzad has nothing to disclose.
-
Miss Siddiqui has nothing to disclose.
-
Miss Khan has nothing to disclose.
-
Dr. Shabbir has nothing to disclose.
-
Dr. Hisham Alamin has nothing to disclose.
-
Mr. Saeed has nothing to disclose.
-
Mr. Abdullah has nothing to disclose.
-
Dr. Ahmed has nothing to disclose.